Candida albicans switch phenotpes display differential levels of fitness

Medical Science Monitor

Volumn 10, Issue 7, 2004, Pages

  Vargas, Kaaren G ^a   Srikantha, Rupasree ^a   Holke, Anamika ^a   Sifri, Tamim ^a   Morris, Ryan ^a   Joly, Sophie ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

Candida albicans; Fitness; HIV; Oral candidiasis; Switching

Indexed keywords

ANTIFUNGAL AGENT; FLUCONAZOLE;

ADAPTATION; ANTIBIOTIC RESISTANCE; ANTIFUNGAL ACTIVITY; ARTICLE; CANDIDA ALBICANS; CANDIDIASIS; CONTROLLED STUDY; DRUG UPTAKE; FITNESS; FUNGAL MORPHOLOGY; FUNGAL STRAIN; FUNGUS GROWTH; FUNGUS ISOLATION; GENE SWITCHING; GROWTH RATE; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MINIMUM INHIBITORY CONCENTRATION; MYCELIUM; NONHUMAN; OPPORTUNISTIC INFECTION; PHENOTYPE; SURVIVAL; THRUSH;

ANTIFUNGAL AGENTS; BLOTTING, SOUTHERN; CANDIDA ALBICANS; CANDIDIASIS; DRUG RESISTANCE, FUNGAL; FLUCONAZOLE; HIV INFECTIONS; HUMANS; PHENOTYPE; TIME FACTORS; TRITIUM;

EID: 3343000250     PISSN: 12341010     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Barchiesi F, Najvar LK, Luther MF et al: Variation in fluconazole efficacy for Candida albicans strains sequentially isolated from oral cavities of patients with AIDS in an experimental murine candidiasis model. Antimicrobial Agents & Chemotherapy, 1996; 40: 1317-20
2. Odds FC, Schmid J, Soll DR: Epidemiology of Candida infections in AIDS. In Vanden Bosshe H, ed. Mycoses in AIDS patients, pp 67-74. New York: Plenum Press, 1990
3. Kaplan JE, Hanson D, Dworkin MS et al: Epidemiology of human immunodeficiency virus-associated opportunistic infections in the United States in the era of highly active antiretroviral therapy. Clinical Infectious Diseases, 2000; 30: S5-S14
4. Laguna F, Rodriguez-Tudela JL, et al: Patterns of fluconazole susceptibility in isolates from human immunodeficiency virus-infected patients with oropharyngeal candidiasis due to Candida albicans. Clinical Infectious Diseases, 1997; 24: 124-30
5. Maenza JR, Merz WG, Romagnoli MJ et al: Infection due to fluconazole-resistant Candida in patients with AIDS: prevalence and microbiology. Clinical Infectious Diseases, 1997; 24: 28-34
6. Luna MA, Tortoledo ME: Histologic identification and pathological patterns of disease due to Candida. In Bodey GP, Fainstein V, eds. Candidiasis, pp 13-27. New York: Raven Press, 1985
7. Soll DR: High-Frequency switching in Candida albicans. Clinical Microbiology Reviews, 1992; 5: 183-203
8. Soll DR: Candida commensalism and virulence: the evolution of phenotypic plasticity. Acta Tropica, 2002; 81: 101-10
9. Borst P, Greaves DR: Programmed DNA rearrangements altering gene expression. Science, 1987; 235: 658-67
10. Slutsky B, Buffo J, Soll DR: High frequency "switching" of colony morphology in Candida albicans. Science, 1985; 230: 666-69
11. Slutsky B, Staebell M, Anderson J et al: "White-opaque transition": a second high-frequency switching system in Candida albicans. Journal of Bacteriology, 1987; 169: 189-97
12. Soll DR: The emerging molecular biology of switching in Candida albicans. ASM News, 1996; 62: 417-20
13. Soll DR: Switching and its possible role in Candida pathogenesis. In Bennett RJHJE, Peterson PK, eds. New strategies in fungal disease, pp 156-78. Endinburgh: Churchille-Livingstone, 1991
14. Odds FC, Merson-Davies LA: Colony variation in Candida species. Mycoses, 1989; 32: 275-82
15. Odds FC: Pathogenesis of Candida infections. Journal of the American Academy of Dermatology, 1994; 31: S2-S5
16. Hellstein J, Vawter-Hugart H, Fotos P et al: Genetic similarity and phenotypic diversity of commensal and pathogenic strains of Candida albicans isolated from the oral cavity. J Clin Microbiol, 1993; 31: 3190-99
17. Gallagher PJ, Bennett DE, Henman MC et al: Reduced azole susceptibility of oral isolates of Candida albicans from HIV-positive patients and a derivative exhibiting colony morphology variation. J Gen Microbiol, 1992; 138: 1901-11
18. Soll DR, Galask R, Isley S et al: Switching of Candida albicans during successive episodes of recurrent vaginitis. J Clin Microbiol, 1989; 27: 681-90
19. Vargas K, Messer SA, Pfaller M et al: Elevated phenotypic switching and drug resistance of Candida albicans from human immunodeficiency virus-positive individuals prior to first thrush episode. J Clin Microbiol, 2000; 38: 3595-607
20. Kiraz N, Ang O, Akgun Y, Erturan Z: Phenotypic Variation and antifungal susceptibility paterns of Candida albicans strains isolated from neutropenic patients. Mycoses, 2000; 43: 119-23
21. Vargas K, Wertz PW, Drake D et al: Differences in adhesion of Candida albicans 3153A cells exhibiting switch phenotypes to buccal epithelium and stratum corneum. Infection & Immunity, 1994; 62: 1328-35
22. 3 of Candida albicans. J Clin Microbiol, 1993; 31: 1472-80
23. 3. J Clin Microbiol, 1999; 37: 2817-28
24. Scherer S, Stevens DA: Application of DNA typing methods to epidemiology and taxonomy of Candida species. J Clin Microbiol, 1987; 25: 675-79
25. Pfaller M, Cabezudo I, Koontz F et al: Predictive value of surveillance cultures for systemic infection due to Candida species. Eur J Clin Microbiol, 1987; 6: 628-33
26. Klepser ME, Ernst JF, Lexis RE et al: Influence of test conditions on antifungal time-kill curve results: proposal for standardized methods. Antimicrobial Agents & Chemotherapy, 1998; 42: 1207-12
27. Pfaller MA, Rex JH, Rinaldi MG: Antifungal susceptibility testing: technical advances and potential clinical applications. Clin Infect Diseases, 1997; 24: 776-84
28. Sanglard D, Kuchler K, Ischer F et al: Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters. Antimicrobial Agents & Chemotherapy, 1995; 39: 2378-86
29. 3 for fingerprinting Candida albicans. J Clin Microbiol, 1997; 35: 2348-58
30. Coote JG: Environmental sensing mechanisms of Bordetella. Advances in Microbial Physiology, 2001; 44: 141-81
31. Levins R: Evolution in changing environments: some theoretical exploration. Princeton University Press, 1968
32. Frank SA: A kin selection model for the evolution of virulence. Proc R Soc Lond, 1992; B250: 195-97
33. Pfenning KS: Evolution of pathogen virulence: the role of variation in host phenotype. Proc R Soc Lond, 2000; 268: 755-60
34. Soll DR, Galask R, Schmid J et al: Genetic dissimilarity of commensal strains of Candida spp. carried in different anatomical locations of the same healthy women. J Clin Microbiol, 1991; 29: 1702-10
35. Whelan WL, Soll DR: Mitotic recombination in Candida albicans: Recessive lethal alleles linked to a gene required for methionine biosynthesis. Mol Gen Genet, 1982; 187: 477-85
36. Zeyl C: Budding yeast as a model organism for population genetics. Yeast, 2000; 16: 773-84
37. Joly S, Pujol C, Soll DR: Microevolutionary changes and chromosomal translocations are more frequent at RPD loci in Candida dubliniensis than in Candida albicans. Infection, Genetics and Evolution, in press
38. White TC: The presence of an R467K amino acid substitution and loss of allelic variation correlate with an azole-resistant lanosterol 14alpha demethylase in Candida albicans. Antimicrobial Agents & Chemotherapy, 1997; 41: 1488-94
39. Morrow B, Srikantha T, Soll DR: Transcription of the gene for a pepsinogen, PEP1, is regulated by white-opaque switching in Candida albicans. Molecular & Cellular Biology, 1992; 12: 2997-3005
40. Ghannoum MA, Swairjo I, Soll DR: Variation in lipid and sterol contents in Candida albicans white and opaque phenotypes. J Med Vet Mycology, 1992; 28: 103-55
41. Kolotila M, Diamond R: Effects of neutrophils and in vitro oxidants on survival and phenotypic switching of Candida albicans WO-1. Infection and Immunity, 1990; 58: 1174-79
42. Soll, David R: High-frequency switching in Candida albicans. Clinical Microbiology Reviews, 1992; 5 (2): 183-203
43. Odds FC: Switch of phenotype as an escape mechanism of the intruder. Mycoses, 1997; 40: 9-12
44. Jones S, White G, Hunter PR: Increased phenotypic switching in strains of Candida albicans asociated with invasive infections. J Clin Microbiol, 1994; 32: 2869-70
45. Perea S, Lopez-Ribot JL, Kirkpatrick WR et al: Prevalence of molecular mechanisms of resistance to azole antifungal agents in Candida albicans strains displaying high-level fluconazole resistance isolated from human immunodeficiency virus-infected patients. Antimicrobial Agents and Chemotherapy, 2001; 45: 2676-84
46. Cowen LE, Sanglard D, Calabrese D et al: Evolution of drug resistance in experimental populations of Candida albicans. J Bacteriology, 2000; 182: 1515-22
47. Cowen LE, Kohn LM, Anderson JB: Divergence in fitness and evolution of drug resistance in experimental populations of Candida albicans. J Bacteriology, 2001; 183: 2971-78
48. Velegraki A, Paplambrou D, Soremi S, Legakis NJ: Variable antifungal susceptibility of wild-type Candida albicans phenotypes from neutropenic hosts. Eur J Clin Microbiol, 1996; 15: 854-60